RxDoctor Payments Data

Kimberly Ashley

Family · New York, NYNPI 1750670394

Payments from drug & device makers

$10,111in general payments, 2019–2025

Across 236 payments — averaging $42.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$6K
  • Cvrx, Inc.$510
  • AstraZeneca$474
  • Merck$432
  • Boehringer Ingelheim$412
  • Abiomed$396
  • plus $2K from 21 others

What the payments were for

  • Consulting fees$2002%
  • Food & beverage$9,91198%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,111 in reported general payments places this provider in the 95th percentile of 8,883 family providers in New York.

See all family providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
UptraviSelexipag29$667,381
OpsumitMacitentan13$172,806
Ambrisentan15$40,770
EntrestoSacubitril/Valsartan29$38,563
JardianceEmpagliflozin14$18,496
EliquisApixaban21$15,315
Sildenafil Citrate20$3,121
Metoprolol Succinate37$498
Rosuvastatin Calcium18$227
Spironolactone27$190
Atorvastatin Calcium16$172
Digoxin15$165
Furosemide13$50

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Actelion Pharmaceuticals US, Inc.Uptravi, Opsumit$28$840,18742 claims
NovartisEntresto$235$38,56329 claims
Boehringer IngelheimJardiance$412$18,49614 claims
PfizerEliquis$18$15,31521 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,883 family providers in New York.

Other family in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →